---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-004199"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:27:00.114220+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma amends convertible note; corrects conversion price, discloses placement agent warrants

## Summary
- Secured convertible note $1.2M principal issued to Lind Global Fund II for $1M purchase price.
- Conversion price amended to lesser of $3.50 fixed or 90% of avg of three lowest VWAPs in prior 20 days.
- First 180 days conversions at fixed $3.50 price if no event of default, per amendment dated Jan 12, 2024.
- Issued Allele Capital placement agent warrants for 30,000 shares at $2.00 per share.
- Lender waives any prior events of default under the transaction documents.

## SEC filing metadata
- accession: 0001213900-24-004199
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/0001213900-24-004199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/ea191466-8ka1_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-004199
- JSON: https://secwatch.observer/filing/0001213900-24-004199.json
- Plain text: https://secwatch.observer/filing/0001213900-24-004199.txt

## Key facts
- Material Agreements
  ABVC BIOPHARMA, INC. amended amendment to the Note with Lind Global Fund II, LP.
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: Lind Global Fund II, LP
  source text: ntered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Lind Global Fund II, LP (“ Lind ”), pursuant to which the Company issued Lind a secured, convertible note in the principal amount of $1,200,000 (the “ Offering ”),
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/0001213900-24-004199-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.